Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy
- DOI
- 10.3389/fimmu.2026.1860823
- Published
- 2026-07-01
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1860823,
title = {Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy},
author = {Zahra Imanifard and Francesca Penati and Sofia Padoa and Paulina Dabrowska-Schlepp and Elena Bresin and Tobia Peracchi and Ariela Benigni and Giuseppe Remuzzi and Marina Noris and Roberta Donadelli},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1860823},
url = {https://doi.org/10.3389/fimmu.2026.1860823}
}RIS
TY - JOUR TI - Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy AU - Zahra Imanifard AU - Francesca Penati AU - Sofia Padoa AU - Paulina Dabrowska-Schlepp AU - Elena Bresin AU - Tobia Peracchi AU - Ariela Benigni AU - Giuseppe Remuzzi AU - Marina Noris AU - Roberta Donadelli PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1860823 UR - https://doi.org/10.3389/fimmu.2026.1860823 ER -
APA
Imanifard, Z., Penati, F., Padoa, S., Dabrowska-Schlepp, P., Bresin, E., Peracchi, T., Benigni, A., Remuzzi, G., Noris, M., & Donadelli, R. (2026). Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1860823
Source records
- crossref · retrieved 2026-09-27T12:24:51.705Z